These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33519819)

  • 1. Local Stabilization of Hypoxia-Inducible Factor-1α Controls Intestinal Inflammation
    Kim YI; Yi EJ; Kim YD; Lee AR; Chung J; Ha HC; Cho JM; Kim SR; Ko HJ; Cheon JH; Hong YR; Chang SY
    Front Immunol; 2020; 11():609689. PubMed ID: 33519819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-155 contributes to intestinal barrier dysfunction in DSS-induced mice colitis via targeting HIF-1α/TFF-3 axis.
    Liu Y; Zhu F; Li H; Fan H; Wu H; Dong Y; Chu S; Tan C; Wang Q; He H; Gao F; Leng X; Zhou Q; Zhu X
    Aging (Albany NY); 2020 Jul; 12(14):14966-14977. PubMed ID: 32713852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis.
    Keely S; Campbell EL; Baird AW; Hansbro PM; Shalwitz RA; Kotsakis A; McNamee EN; Eltzschig HK; Kominsky DJ; Colgan SP
    Mucosal Immunol; 2014 Jan; 7(1):114-23. PubMed ID: 23695513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia inducible factor-1α-induced interleukin-33 expression in intestinal epithelia contributes to mucosal homeostasis in inflammatory bowel disease.
    Sun M; He C; Wu W; Zhou G; Liu F; Cong Y; Liu Z
    Clin Exp Immunol; 2017 Mar; 187(3):428-440. PubMed ID: 27921309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological HIF-1 stabilization promotes intestinal epithelial healing through regulation of α-integrin expression and function.
    Goggins BJ; Minahan K; Sherwin S; Soh WS; Pryor J; Bruce J; Liu G; Mathe A; Knight D; Horvat JC; Walker MM; Keely S
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G420-G438. PubMed ID: 33470153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of hypoxia-inducible factor 1-alpha in inflammatory bowel disease.
    Yin J; Ren Y; Yang K; Wang W; Wang T; Xiao W; Yang H
    Cell Biol Int; 2022 Jan; 46(1):46-51. PubMed ID: 34658125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCFAs induce autophagy in intestinal epithelial cells and relieve colitis by stabilizing HIF-1α.
    Zhou C; Li L; Li T; Sun L; Yin J; Guan H; Wang L; Zhu H; Xu P; Fan X; Sheng B; Xiao W; Qiu Y; Yang H
    J Mol Med (Berl); 2020 Aug; 98(8):1189-1202. PubMed ID: 32696223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation.
    Marks E; Naudin C; Nolan G; Goggins BJ; Burns G; Mateer SW; Latimore JK; Minahan K; Plank M; Foster PS; Callister R; Veysey M; Walker MM; Talley NJ; Radford-Smith G; Keely S
    Mucosal Immunol; 2017 Sep; 10(5):1224-1236. PubMed ID: 28120851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor hydroxylase inhibition enhances the protective effects of cyclosporine in colitis.
    Halligan DN; Khan MN; Brown E; Rowan CR; Coulter IS; Doherty GA; Tambuwala MM; Taylor CT
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G90-G97. PubMed ID: 31070931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxylase inhibition abrogates TNF-alpha-induced intestinal epithelial damage by hypoxia-inducible factor-1-dependent repression of FADD.
    Hindryckx P; De Vos M; Jacques P; Ferdinande L; Peeters H; Olievier K; Bogaert S; Brinkman B; Vandenabeele P; Elewaut D; Laukens D
    J Immunol; 2010 Nov; 185(10):6306-16. PubMed ID: 20943999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral delivery of prolyl hydroxylase inhibitor: AKB-4924 promotes localized mucosal healing in a mouse model of colitis.
    Marks E; Goggins BJ; Cardona J; Cole S; Minahan K; Mateer S; Walker MM; Shalwitz R; Keely S
    Inflamm Bowel Dis; 2015 Feb; 21(2):267-75. PubMed ID: 25545377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurotensin-HIF-1α-VEGFα axis orchestrates hypoxia, colonic inflammation, and intestinal angiogenesis.
    Bakirtzi K; West G; Fiocchi C; Law IK; Iliopoulos D; Pothoulakis C
    Am J Pathol; 2014 Dec; 184(12):3405-14. PubMed ID: 25307345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of CD36 and thrombospondin-1 in macrophages by hypoxia-inducible factor 1 and its relevance in the inflammatory process.
    Ortiz-Masià D; Díez I; Calatayud S; Hernández C; Cosín-Roger J; Hinojosa J; Esplugues JV; Barrachina MD
    PLoS One; 2012; 7(10):e48535. PubMed ID: 23119050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen sensing in intestinal mucosal inflammation.
    Flück K; Fandrey J
    Pflugers Arch; 2016 Jan; 468(1):77-84. PubMed ID: 26206140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition.
    Robinson A; Keely S; Karhausen J; Gerich ME; Furuta GT; Colgan SP
    Gastroenterology; 2008 Jan; 134(1):145-55. PubMed ID: 18166352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutual regulation between butyrate and hypoxia-inducible factor-1α in epithelial cell promotes expression of tight junction proteins.
    Yin J; Zhou C; Yang K; Ren Y; Qiu Y; Xu P; Xiao W; Yang H
    Cell Biol Int; 2020 Jun; 44(6):1405-1414. PubMed ID: 32129567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia.
    Morote-Garcia JC; Rosenberger P; Nivillac NM; Coe IR; Eltzschig HK
    Gastroenterology; 2009 Feb; 136(2):607-18. PubMed ID: 19105964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal inflammation downregulates PHD1 expression promoting a barrier-protective HIF-1α response in ulcerative colitis patients.
    Brown E; Rowan C; Strowitzki MJ; Fagundes RR; Faber KN; Güntsch A; Halligan DN; Kugler J; Jones F; Lee CT; Doherty G; Taylor CT
    FASEB J; 2020 Mar; 34(3):3732-3742. PubMed ID: 31944416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of HIF through inhibition of Cullin-2 neddylation is protective in mucosal inflammatory responses.
    Curtis VF; Ehrentraut SF; Campbell EL; Glover LE; Bayless A; Kelly CJ; Kominsky DJ; Colgan SP
    FASEB J; 2015 Jan; 29(1):208-15. PubMed ID: 25326537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.